| 1 | 
                
                    Acetate
                
             | 1件:  Acetate Acetate | - | - | - | 43件:  1 1, 2, 6, 10, 13, 35, 40, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 227, 235, 265, 288, 298, 299 | 
| 2 | 
                
                    Adalimumab
                
             | 6件:  Adalimumab Adalimumab; Amgevita; Hulio; Humira; Hyrimoz; Imraldi | 1件:  D02597 
                
                    D02597
                
             | 1件:  TNF TNF 💬 | 67件:  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 18件:  19 19, 37, 40, 41, 46, 56, 84, 96, 97, 107, 151, 160, 164, 222, 226, 269, 270, 271 | 
| 3 | 
                
                    Clofarabine
                
             | 1件:  Clofarabine Clofarabine | 1件:  D03546 
                
                    D03546
                
             | 3件:  POLA1 POLA1, POLA2, RRM1 💬 | 6件:  DNA replication DNA replication, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 💬 | 9件:  19 19, 20, 40, 46, 49, 60, 96, 234, 326 | 
| 4 | 
                
                    Cyclophosphamide
                
             | 6件:  Ciclofosfamida Ciclofosfamida; Ciclofosfamide; Cyclophosphamid; Cyclophosphamide; Cyclophosphamidum; Cytoxan | 2件:  D00287 
                
                    D00287
                
            , 
                
                    D07760
                
             | - | - | 45件:  11 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 205, 222, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 | 
| 5 | 
                
                    Cyclosporine
                
             | 10件:  Ciclosporin Ciclosporin; Ciclosporina; Ciclosporine; Cyclosporin; Cyclosporin A; Cyclosporine; Cyclosporine A; Ikervis; NEORAL; RESTASIS | 1件:  D00184 
                
                    D00184
                
             | 5件:  PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | 33件:  Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 44件:  11 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 | 
| 6 | 
                
                    Dichlorobenzene
                
             | 0件:  | - | - | - | 1件:  40 40 | 
| 7 | 
                
                    Filgrastim
                
             | 7件:  Filgrastim Filgrastim; Filgrastim Hexal; G-CSF; GRANULOCYTE COLONY STIMULATING FACTOR; Neupogen; TEVAGRASTIM; ZARZIO | 1件:  D03235 
                
                    D03235
                
             | 1件:  CSF3R CSF3R 💬 | 5件:  Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 34件:  2 2, 6, 11, 13, 16, 25, 26, 28, 34, 35, 36, 38, 40, 41, 42, 45, 46, 47, 49, 51, 57, 60, 62, 65, 85, 96, 113, 164, 256, 283, 284, 285, 296, 331 | 
| 8 | 
                
                    Infliximab
                
             | 6件:  Flixabi Flixabi; INFLECTRA; Infliximab; Remicade; REMSIMA; Zessly | 1件:  D02598 
                
                    D02598
                
             | 1件:  TNF TNF 💬 | 67件:  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 27件:  35 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 | 
| 9 | 
                
                    Leflunomide
                
             | 3件:  Arava Arava; Leflunomide; Leflunomidum | 1件:  D00749 
                
                    D00749
                
             | 1件:  DHODH DHODH 💬 | 3件:  Biosynthesis of cofactors Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬 | 12件:  11 11, 40, 46, 49, 53, 66, 107, 162, 224, 270, 271, 300 | 
| 10 | 
                
                    Methotrexate
                
             | 6件:  Methotrexat Methotrexat; Methotrexate; METHOTREXATE SODIUM; Metoject; METOTREXATO; Méthotrexate | 2件:  D00142 
                
                    D00142
                
            , 
                
                    D02115
                
             | 2件:  DHFR DHFR, DHFR2 💬 | 5件:  Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 38件:  11 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 283, 284, 285, 286, 326, 331 | 
| 11 | 
                
                    Methylprednisolone
                
             | 4件:  Medrol Medrol; Methylprednisolon; Methylprednisolone; Methylprednisolone acetate | 6件:  D00407 
                
                    D00407
                
            , 
                
                    D00751
                
            , 
                
                    D00979
                
            , 
                
                    D05000
                
            , 
                
                    D05001
                
            , 
                
                    D05002
                
             | 1件:  NR3C1 NR3C1 💬 | 1件:  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 48件:  2 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 86, 93, 95, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296, 300 | 
| 12 | 
                
                    Monomethyl fumarate
                
             | 2件:  Bafiertam Bafiertam; Monomethyl fumarate | 1件:  D11492 
                
                    D11492
                
             | - | - | 15件:  13 13, 35, 40, 46, 49, 50, 51, 60, 65, 66, 162, 222, 224, 226, 299 | 
| 13 | 
                
                    Naltrexone
                
             | 2件:  Naltrexone Naltrexone; Naltrexone Hydrochloride | 2件:  D02095 
                
                    D02095
                
            , 
                
                    D05113
                
             | 3件:  OPRD1 OPRD1, OPRK1, OPRM1 💬 | 5件:  Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 13件:  6 6, 10, 13, 40, 41, 42, 43, 44, 45, 46, 96, 97, 226 | 
| 14 | 
                
                    Prednisolone
                
             | 3件:  Prednisolona Prednisolona; Prednisolone; Prednisolonum | 8件:  D00472 
                
                    D00472
                
            , 
                
                    D00980
                
            , 
                
                    D00981
                
            , 
                
                    D00982
                
            , 
                
                    D01239
                
            , 
                
                    D01998
                
            , 
                
                    D02156
                
            , 
                
                    D03301
                
             | 1件:  NR3C1 NR3C1 💬 | 1件:  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 43件:  3 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300, 307 | 
| 15 | 
                
                    Prednisone
                
             | 3件:  Prednisona Prednisona; Prednisone; RAYOS | 1件:  D00473 
                
                    D00473
                
             | 1件:  NR3C1 NR3C1 💬 | 1件:  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 48件:  2 2, 6, 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 95, 96, 97, 113, 127, 162, 164, 205, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 | 
| 16 | 
                
                    Prednisone acetate
                
             | 2件:  CORTANCYL CORTANCYL; Prednisone acetate | 1件:  D08416 
                
                    D08416
                
             | 1件:  NR3C1 NR3C1 💬 | 1件:  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 7件:  35 35, 40, 41, 46, 49, 162, 224 | 
| 17 | 
                
                    Tocilizumab
                
             | 3件:  ACTEMRA ACTEMRA; ROACTEMRA; Tocilizumab | 1件:  D02596 
                
                    D02596
                
             | 1件:  IL6R IL6R 💬 | 12件:  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 21件:  2 2, 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 | 
| 18 | 
                
                    Tofacitinib
                
             | 4件:  Tasocitinib Tasocitinib; Tofacitinib; XELJANZ; Xeljanz XR | 1件:  D09970 
                
                    D09970
                
             | 4件:  JAK1 JAK1, JAK2, JAK3, TYK2 💬 | 37件:  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 15件:  11 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 256, 271 | 
| 19 | 
                
                    Upadacitinib
                
             | 2件:  Rinvoq Rinvoq; Upadacitinib | 1件:  D10994 
                
                    D10994
                
             | 1件:  JAK1 JAK1 💬 | 27件:  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 8件:  40 40, 41, 46, 49, 96, 97, 107, 271 | 
| 20 | 
                
                    Ustekinumab
                
             | 2件:  STELARA STELARA; Ustekinumab | 1件:  D09214 
                
                    D09214
                
             | 3件:  IL12A IL12A, IL12B, IL23A 💬 | 28件:  African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | 17件:  37 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 | 
| 21 | 
                
                    Yellow fever vaccine
                
             | 1件:  Yellow fever vaccine Yellow fever vaccine | 1件:  D06347 
                
                    D06347
                
             | - | - | 8件:  40 40, 44, 46, 50, 51, 52, 53, 107 |